STOCK TITAN

Fosun International Holds 2025 Annual Results Presentation: Fosun has the Ability to Navigate Through Cycles

(Neutral)
(Positive)
Tags

Fosun International (OTC:FOSUF) reported 2025 revenue of RMB173.43 billion and adjusted industrial operation profit of RMB4 billion. Adjusted NAV was RMB133.5 billion (NAV per share HKD18.1). The Group booked a RMB23.4 billion non-cash impairment, largely real estate-related.

Core units generated RMB128.2 billion (74% of revenue); Fosun Pharma net profit rose 21.69% to RMB3.371 billion. Management announced a share buyback, asset disposals, a USD205 million bond tender, and targets to exceed RMB10 billion net profit and cut interest-bearing debt below RMB60 billion.

Loading...
Loading translation...

Positive

  • Total revenue of RMB173.43 billion
  • Fosun Pharma net profit up 21.69% to RMB3.371 billion
  • Adjusted NAV RMB133.5 billion; NAV per share HKD18.1
  • Core subsidiaries generated RMB128.2 billion (74% of Group revenue)
  • Completed USD205 million tender offer for May 2026 bonds

Negative

  • Non-cash book loss of RMB23.4 billion in 2025
  • Real estate impairments accounted for ~55% of the RMB23.4 billion loss
  • Non-core asset impairments accounted for ~45% of the RMB23.4 billion loss

Market Context

This announcement outlines 2025 results with revenue of RMB173.43 billion, strong contributions from...
Analysis

This announcement outlines 2025 results with revenue of RMB173.43 billion, strong contributions from core subsidiaries, and a large non-cash impairment driving a RMB23.4 billion book loss. Management stresses divesting low-return assets, growing core health, insurance and tourism operations, and targeting net profit above RMB10 billion while reducing interest‑bearing debt below RMB60 billion. Investors may track progress on asset sales, bond repurchases of USD205 million, and segment-level profit growth to gauge execution on this strategy.

Key Figures

Total revenue: RMB173.43 billion Adj. industrial operation profit: RMB4 billion Adjusted NAV: RMB133.5 billion +5 more
8 metrics
Total revenue RMB173.43 billion Group revenue for 2025 reporting period
Adj. industrial operation profit RMB4 billion Adjusted industrial operation profit in 2025 reporting period
Adjusted NAV RMB133.5 billion Fosun International adjusted net asset value in 2025
NAV per share HKD18.1 Adjusted NAV per share in 2025
Core subsidiaries revenue RMB128.2 billion Revenue from four core subsidiaries, 74% of total revenue
Fosun Pharma net profit RMB3.371 billion Net profit to shareholders, up 21.69% year-on-year
Book loss 2025 RMB23.4 billion Book loss from impairments and revaluations in 2025
USD bonds tender offer USD205 million Full tender offer for bonds maturing May 2026 at 100% of par

Historical Context

5 past events · Latest: Dec 21 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Dec 21 ESG award recognition Positive +1.8% TVB Outstanding ESG Award and related ESG achievements highlighted.
Nov 20 ESG award recognition Positive -5.2% Bloomberg Businessweek ESG Leading Enterprise honor and ESG metrics.
Nov 06 ESG awards & healthcare Positive -5.2% Gold Award and Best Sustainability Team with global ESG credentials.
Nov 06 Innovation showcase Positive -5.2% CIIE participation showcasing oncology and CAR-T innovations and devices.
Oct 30 Branding initiative Positive -5.2% Launch of International Jewelry Fashion Theme Month in Shanghai.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent positive corporate and ESG news often saw negative next-day moves, suggesting a tendency for good news to be faded, with only one event showing aligned upside.

Recent Company History

Over the past six months, Fosun’s news flow focused on ESG recognition, healthcare innovation, and branding initiatives. Awards from TVB, Bloomberg Businessweek and The Asset highlighted strong sustainability credentials and global healthcare reach. Other updates promoted international jewelry and fashion positioning. Price reactions to these largely positive headlines skewed negative, with four events seeing around -5.24% moves, and only one ESG award-related release coinciding with a +1.83% gain. Today’s annual results narrative fits into a pattern of emphasizing stability and long-term value.

Key Terms

non-cash impairment, goodwill, intangible assets, net asset value, +4 more
8 terms
non-cash impairment financial
"Fosun made non-cash impairment provisions and value revaluations on certain real estate projects..."
A non-cash impairment is a reduction in a company's asset value that doesn't involve actual money changing hands. It happens when an asset, like equipment or a building, becomes less useful or less valuable than it was before, and the company needs to record that loss in its financial reports. This matters because it shows the true worth of what the company owns and can affect its overall financial health.
goodwill financial
"...as well as goodwill and intangible assets of certain non-core business segments."
Goodwill is the extra value a buyer pays for a company above the measurable worth of its buildings, inventory and other tangible items, reflecting things like brand reputation, customer loyalty and expected future profits. Think of paying more for a café because of its famous name and regulars rather than its furniture alone. It matters to investors because changes in goodwill — for example a write-down if expected benefits don’t materialize — can reduce reported earnings and signal that past acquisitions aren’t delivering as hoped.
View in glossary
intangible assets financial
"...goodwill and intangible assets of certain non-core business segments."
Non-physical resources a company owns that help it earn money, such as brand names, patents, customer lists, proprietary software, or trade secrets — think of them as a company’s reputation, recipes, or secret formulas that aren’t bricks and mortar. Investors care because these assets can create long-term income, protect market share, and boost the value of a business even if they don’t appear as cash; strong intangible assets can mean higher future profits and lower risk of competitors copying a company’s advantages.
View in glossary
net asset value financial
"Fosun International's adjusted net asset value (NAV) was RMB133.5 billion..."
Net asset value is the total value of an investment fund's assets minus any liabilities, divided by the number of shares or units outstanding. It represents the per-share worth of the fund, similar to how the value of a house is determined by its total worth after debts are subtracted. Investors use it to gauge the true value of their holdings and to compare different investment options.
View in glossary
credit bonds financial
"...successfully issued multiple 2-year credit bonds domestically..."
Debt securities issued by companies, banks, or other non-government borrowers that pay periodic interest and promise to return the loaned amount at maturity; think of them as formal IOUs from a business. They matter to investors because the interest (yield) compensates for the risk the borrower might not repay — higher perceived risk usually means higher yield — so credit bonds are used for income, diversification, and for betting on a borrower's financial health.
tender offer financial
"...announcement earlier today of a full tender offer to repurchase its remaining US dollar bonds..."
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
View in glossary
par value financial
"...totaling approximately USD205 million, at 100% of par value..."
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
interest‑bearing debt financial
"...reducing the Group's interest‑bearing debt to below RMB60 billion..."
Interest-bearing debt is money a company has borrowed that requires regular interest payments, such as bank loans, bonds, or credit lines. It matters to investors because these payments reduce cash available for growth or dividends and increase financial risk—similar to how a household mortgage limits what you can spend each month; high levels can squeeze profits and make a company more vulnerable in downturns.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

HONG KONG, April 1, 2026 /PRNewswire/ -- On 31 March, Fosun International held its 2025 annual results presentation in Shanghai. Guo Guangchang, Chairman of Fosun International; Wang Qunbin, Co-Chairman of Fosun International; Chen Qiyu, Co-CEO of Fosun International; Xu Xiaoliang, Co-CEO of Fosun International; Gong Ping, CFO of Fosun International, as well as a number of institutional investors and analysts attended the event.

On the evening of 30 March, Fosun International announced its 2025 annual results. During the Reporting Period, the Group's total revenue reached RMB173.43 billion, and adjusted industrial operation profit was RMB4 billion. Fosun International's adjusted net asset value (NAV) was RMB133.5 billion, with a NAV per share reaching HKD18.1. Its four core subsidiaries generated RMB128.2 billion in revenue, accounting for 74% of the Group's total revenue. Among them, Fosun Pharma achieved a net profit attributable to shareholders of the parent of RMB3.371 billion, representing a year-on-year increase of 21.69%. Fosun Insurance Portugal achieved a net profit attributable to owners of the parent of EUR201 million, up 15.8% year-on-year.

Compared to prior years, Fosun's results have largely remained stable. However, Fosun made non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators, as well as goodwill and intangible assets of certain non-core business segments. This resulted in a book loss of RMB23.4 billion in 2025, of which real estate-related impairment accounted for approximately 55%, while impairment of non-core assets accounted for approximately 45%. These provisions do not affect the Company's overall operations and cash flow.

"Repairing the roof on a sunny day"

Guo Guangchang, Chairman of  Fosun International, emphasized that this impairment is akin to "repairing the roof on a sunny day", and from a long-term perspective, this impairment marks Fosun's entry into a new stage of development. "We will divest assets with low profitability and value below target, and focus our resources on core, high‑growth areas, steering the Company toward a leaner, healthier, and more sustainable future."

He explained that the operating results of Fosun's various business segments indicate that Fosun's core businesses remain solid. The pharmaceutical business has continued to make breakthroughs in its global expansion, with multiple products launched overseas and several promising pipeline products. The insurance business recorded growth both domestically and internationally, with Fosun Insurance Portugal expanding its business into regions such as Latin America and Africa. Meanwhile, domestic insurance companies, Fosun United Health Insurance and Pramerica Fosun Life Insurance, recorded significant profit increases. In the culture and tourism business, Club Med achieved record-high results.

"These businesses are capable of generating sustainable profit and cash flow, laying the foundation for Fosun's continued growth. Following this significant impairment, Fosun's future operating results will more accurately reflect the underlying quality of our core businesses," said Guo Guangchang.

No further impairment pressure is expected going forward

Following Fosun's results announcement, one of the market's key concern is the Company's future impairment pressure. At the results presentation, Wang Qunbin, Co-Chairman of Fosun International, stated that from the Group's perspective, prudent and adequate provisions were made, taking into account the actual operating environment of each impaired asset, the valuation cycle of the industry in which the asset operates, the projected growth and development of these assets and industries, and in accordance with the principle of prudence and the requirements of Hong Kong accounting standards. At present, Fosun is not expected to face further impairment pressure going forward. Since the Group announced its asset impairment, Fosun's management has proactively and promptly engaged with rating agencies, major partner banks and public bond investors, and has gained recognition from partners.

Wang Qunbin stated that while Fosun is confident in its financing capabilities in the future, and the domestic and international financing landscape and costs have improved significantly, Fosun remains committed to "streamlining operations and strengthening the business", focusing on development, and continuously improving its ratings.

High-quality breakthroughs in multiple core business areas

Regarding Fosun's key business directions, Chen Qiyu, Co-CEO of Fosun International, stated that Fosun will continue to focus on its core businesses to drive medium-to long-term value growth.

First, it will focus on its innovation and globalization strategies to pursue better and more sustainable value. Second, Fosun's robust global insurance business will drive healthy profit and cash flow growth, serving an important cornerstone for Fosun's future profit growth. Third, it will continue to advance the asset-light and global operations of its culture and tourism business to better leverage resources and drive efficient growth. In addition, it will strive to upgrade and achieve breakthroughs in high-quality assets and businesses such as Yuyuan's gold and jewelry business, Shede Spirits, and Hainan Mining.

Xu Xiaoliang, Co-CEO of Fosun International, stated that despite the high degree of uncertainty in the global macroeconomic environment last year, Fosun continued to optimize its financial structure and steadily enhanced business operations by focusing on its core businesses. It also achieved high-quality breakthroughs in multiple core business areas.

Revenue from its four major business segments—Health, Happiness, Wealth, and Intelligent Manufacturing—saw steady growth, overseas revenue continued to increase, innovation became a core competitive advantage, globalization accelerated further, and global operational capabilities continued to strengthen. Going forward, Fosun will continue to deepen its strategic focus, strengthen its global operational capabilities, intensify innovation efforts, and invest in the future with greater composure and determination to achieve long-term, sustainable value growth.

Fully confident in the Company's future development

Regarding external concerns about Fosun's financing channels and debt, Gong Ping, CFO of Fosun International, stated that the Group's diversified financing channels remain open and its cost of debt is steadily declining. Since 2025, Fosun International has completed four long-term bond issuances overseas and successfully issued multiple 2-year credit bonds domestically, effectively extending debt maturity and optimizing debt structure. The proportion of medium- and long-term debt has increased from 48.7% in 2024 to 53.5%. This includes Fosun's announcement earlier today of a full tender offer to repurchase its remaining US dollar bonds maturing in May 2026, totaling approximately USD205 million, at 100% of par value, with the repurchase funded by the Group's own funds.

Gong Ping added that Fosun will take a multi-pronged approach to streamline the Group's asset portfolio and enhance transparency, thereby accelerating valuation recovery. Management has set a clear  medium-term target of achieving a net profit attributable to shareholders of the parent of more than RMB10 billion, mainly by accelerating the sale of asset-heavy projects and non-core subsidiaries, optimizing the asset portfolio, reducing the Group's interest‑bearing debt to below RMB60 billion, and lowering financial expenses. At the same time, Fosun will actively explore ways to bring non-listed assets to the capital market.

Fosun's management expressed full confidence in the Company's future development at the results presentation. The Company's Board of Directors has announced a share buyback program. Fosun's major shareholder and management team will also increase their holdings in the shares of the Company. In the future, Fosun will actively explore and gradually introduce further measures to enhance shareholder returns, including optimizing the dividend mechanism, in line with operational improvements and cash flow conditions.

"I believe Fosun has the ability to navigate through cycles. While we may face some short-term challenges, these efforts will position Fosun for steadier, longer-term growth," said Guo Guangchang.

Cision View original content:https://www.prnewswire.com/news-releases/fosun-international-holds-2025-annual-results-presentation-fosun-has-the-ability-to-navigate-through-cycles-302731273.html

SOURCE Fosun

FAQ

What were Fosun International's reported 2025 revenues and adjusted NAV (FOSUF)?

Fosun reported RMB173.43 billion in 2025 revenue and an adjusted NAV of RMB133.5 billion. According to the company, NAV per share reached HKD18.1, reflecting post-impairment asset valuations.

How large was Fosun's 2025 impairment and what drove the loss (FOSUF)?

Fosun recorded a RMB23.4 billion non-cash book loss in 2025, mainly impairment-driven. According to the company, about 55% related to real estate and 45% to non-core business assets.

What were key profit contributors for Fosun in 2025, including Fosun Pharma (FOSUF)?

Core businesses produced strong results; Fosun Pharma posted net profit of RMB3.371 billion, up 21.69%. According to the company, four core subsidiaries made up 74% of Group revenue.

What debt and capital actions did Fosun announce at the April 1, 2026 presentation (FOSUF)?

Fosun initiated a share buyback and completed a USD205 million tender offer for May 2026 bonds. According to the company, it aims to reduce interest-bearing debt below RMB60 billion.

Does Fosun expect further impairment pressure after the 2025 adjustments (FOSUF)?

Management said no further impairment pressure is expected and provisions were prudently made. According to the company, rating agencies and lenders have been engaged and financing access remains open.

What medium-term financial targets did Fosun set after the 2025 results (FOSUF)?

Fosun set a medium-term target of > RMB10 billion net profit attributable to shareholders and lowering interest-bearing debt below RMB60 billion. According to the company, asset sales and portfolio optimization will support these goals.